2021
DOI: 10.3389/fmolb.2021.770808
|View full text |Cite
|
Sign up to set email alerts
|

Platinum-Induced Peripheral Neuropathy (PIPN): ROS-Related Mechanism, Therapeutic Agents, and Nanosystems

Abstract: Platinum (Pt) drugs (e.g., oxaliplatin, cisplatin) are applied in the clinic worldwide for the treatment of various cancers. However, platinum-induced peripheral neuropathy (PIPN) caused by the accumulation of Pt in the peripheral nervous system limits the clinical application, whose prevention and treatment are still a huge challenge. To date, Pt-induced reactive oxygen species (ROS) generation has been studied as one of the primary mechanisms of PIPN, whose downregulation would be feasible to relieve PIPN. T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 108 publications
(125 reference statements)
0
6
0
Order By: Relevance
“…The current author proposes that primary afferent peripheral terminal hyperexcitation with “leakiness” at Piezo2 is such a pathological condition in DOMS. Accordingly, it is not surprising that platinum-analogue drugs also elevate ROS production as the primary mechanism of platinum-induced peripheral neuropathy [ 110 ] with the activation of the NF-kappa B pathway [ 111 ].…”
Section: Oxidative Stress and Redox Imbalancementioning
confidence: 99%
“…The current author proposes that primary afferent peripheral terminal hyperexcitation with “leakiness” at Piezo2 is such a pathological condition in DOMS. Accordingly, it is not surprising that platinum-analogue drugs also elevate ROS production as the primary mechanism of platinum-induced peripheral neuropathy [ 110 ] with the activation of the NF-kappa B pathway [ 111 ].…”
Section: Oxidative Stress and Redox Imbalancementioning
confidence: 99%
“…Excessive ROS generation induced by platinum agents such as oxaliplatin, that leads to oxidative stress and mitochondrial dysfunction, contribute to the development of CIPN. 45,76 DRG neurons exposed to oxaliplatin in vitro induced a dose-dependent and time-dependent mitochondrial production of ROS. 50,63 Given the observed enrichment of ETC components following MTM rescue, we investigated whether DRG neurons increased their content of ROS in response to oxaliplatin treatment in vivo and if MTM treatment could reverse this effect.…”
Section: Resultsmentioning
confidence: 94%
“…Platinum-based chemotherapy agents like cisplatin and oxaliplatin accumulate and form DNA adducts in DRG that induce DNA/ mitochondrial damage, enhancing reactive oxygen species (ROS) production while activating nociceptor-associated channels. 45,63,76,102 Exactly how oxaliplatin or other platinum chemotherapy increase mitochondrial ROS is poorly understood. Nevertheless, increased mitochondrial ROS levels are associated with cisplatin's and oxaliplatin's neurotoxicity in painful CIPN.…”
Section: Mitochondria and Mithramycinmentioning
confidence: 99%
“…In line with the aforementioned, platinum analogue chemotherapeutic drug-induced ROS production contributes to peripheral neuropathy [ 118 ], with NF-κB pathway activation [ 119 ]. The ROS derived NF-κB activation may also have a role in muscle cells as well, with associated NGF upregulation on them [ 120 ].…”
Section: Agingmentioning
confidence: 99%